Ardelyx Announces Positive Second Data Analysis from Ongoing NOR
ARDX: Ardelyx
2020-06-15 08:00:00
Ardelyx Announces Positive Second Data Analysis from Ongoing NORMALIZE Phase 4 Study Evaluating Tenapanor in CKD Patients on Dialysis
2020-06-15 08:00:00
Ardelyx Announces Positive Second Data Analysis from Ongoing NORMALIZE Phase 4 Study Evaluating Tenapanor in CKD Patients on Dialysis